Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	93983
Country	China

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Hui Wan, Yu-Xin Zhang, Guan-Yue Shan, Jun-Ya Cheng, Duan-Rui Qiao, Yi-Ying Liu, Wen-Na Shi and Hai-Jun Li
Funding Agency and Grant Number	Funding Agency Grant Number Natural Science Foundation of China No. 81970529 Natural Science Foundation of Jilin Province No. 20230508074RC Natural Science Foundation of Jilin Province No. YDZJ202401218ZYTS
Corresponding Author	Hai-Jun Li, MD, PhD, Associate Professor, Institute of Liver Diseases, Institute of Translational Medicine, The First Hospital of Jilin University, No. 71 Xinmin Street, Changchun 130061, Jilin Province, China. hjli2012@jlu.edu.cn
Key Words	Hepatitis B virus; Hepatocellular carcinoma; Hepatitis B virus-DNA; Immune tolerance; Antiviral therapy
Core Tip	Hepatocellular carcinoma (HCC) is the seventh most common cancer in the world and is usually associated with hepatitis B virus (HBV) infection. Radical resection and antiviral therapy are considered key clinical treatments for patients with HBV-related HCC. However, many patients have their HCC and HBV infection detected at the same time, so they receive remedial antiviral treatment beginning in the perioperative period, missing the opportunity for long-term preoperative antiviral therapy. Therefore, evaluating the clinical efficacy and relevant factors of perioperative remedial antiviral therapy will be valuable.
Citation	Wan H, Zhang YX, Shan GY, Cheng JY, Qiao DR, Liu YY, Shi WN, Li HJ. Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma. World J Gastrointest Oncol 2025; In press

Received	2024-03-09 10:48
Peer-Review Started	2024-03-09 10:48
To Make the First Decision
Return for Revision	2024-09-10 02:03
Revised	2024-09-20 05:47
Second Decision	2024-09-29 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-29 08:23
Articles in Press	2024-09-29 08:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com